Former colleague David Hangauer was selected as the 2021 Schoellkopf Medalist from the WNY section of the ACS. Dave was selected for his “visionary work on the discovery of cancer therapies and his entrepreneurial impact for the advancement of the pharmaceutical industry in the region.” Dave will be honored at the Schoellkopf Award banquet, which is tentatively scheduled for April 5, 2022.